{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:16:29Z","timestamp":1780481789821,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Occult metastases in axillary lymph nodes have been reported to be associated with poor prognosis in patients with breast cancer. However, studies on the prognostic value of occult metastases have shown controversial results. This meta-analysis aimed to evaluate the prognostic significance of occult lymph node metastases in breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Studies published until May, 2020, which retrospectively examined negative lymph nodes by stepsectioning and\/or immunohistochemistry, were retrieved from MEDLINE, EMBASE, CNKI, and Cochrane Library databases. The pooled Relative Risk (RR) with 95% confidence interval (95% CI) for overall survival (OS) and disease-free survival (DFS) were calculated to examine the associations between occult metastases and prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with occult metastases in axillary lymph nodes had poorer five-year DFS (RR\u2009=\u20090.930; 95% CI\u2009=\u20090.907\u20130.954) and OS (RR\u2009=\u20090.972; 95% CI\u2009=\u20090.954\u20130.990). Furthermore, the DFS (RR\u2009=\u20090.887; 95% CI\u2009=\u20090.810\u20130.972) and OS (RR\u2009=\u20090.896; 95% CI\u2009=\u20090.856\u20130.939) of patients with occult metastases were significantly lower after a ten-year follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Occult metastases in the axillary lymph nodes are associated with poorer DFS andOS of patients with breast cancer. Occult metastases might serve as a predictive factor of survival outcomes in patients with breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-08582-1","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T22:06:24Z","timestamp":1627682784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prognostic significance of occult lymph node metastases in breast cancer: a meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Guixin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianjun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"key":"8582_CR1","doi-asserted-by":"publisher","unstructured":"Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update Cancer. 1983;52(9):1551\u20137. https:\/\/doi.org\/10.1002\/1097-0142(19831101)52:9<1551::aid-cncr2820520902>3.0.co;2-3.","DOI":"10.1002\/1097-0142(19831101)52:9<1551::aid-cncr2820520902>3.0.co;2-3"},{"key":"8582_CR2","first-page":"140","volume":"17","author":"O Saphir","year":"1948","unstructured":"Saphir O, Amromin GD. Obscure axillary lymph node metastases in carcinoma of the breast. Proc Inst Med Chic. 1948;17:140.","journal-title":"Proc Inst Med Chic"},{"issue":"6","key":"8582_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/jnci\/djq008","volume":"102","author":"M de Boer","year":"2010","unstructured":"de Boer M, van Dijck JA, Bult P, Borm GF, Tjan-Heijnen VC. Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst. 2010;102(6):410\u201325. https:\/\/doi.org\/10.1093\/jnci\/djq008.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"8582_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/path.1711650305","volume":"165","author":"MH Galea","year":"1991","unstructured":"Galea MH, Athanassiou E, Bell J, Dilks B, Robertson JF, Elston CW, et al. Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11. J Pathol. 1991;165(3):221\u20137. https:\/\/doi.org\/10.1002\/path.1711650305.","journal-title":"J Pathol"},{"issue":"1","key":"8582_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/bjc.1996.16","volume":"73","author":"MA McGuckin","year":"1996","unstructured":"McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer. 1996;73(1):88\u201395. https:\/\/doi.org\/10.1038\/bjc.1996.16.","journal-title":"Br J Cancer"},{"issue":"3","key":"8582_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/sj.bjc.6600070","volume":"86","author":"RR Millis","year":"2002","unstructured":"Millis RR, Springall R, Lee AH, Ryder K, Rytina ER, Fentiman IS. Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer. 2002;86(3):396\u2013401. https:\/\/doi.org\/10.1038\/sj.bjc.6600070.","journal-title":"Br J Cancer"},{"issue":"3","key":"8582_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1075-122X.2004.21328.x","volume":"10","author":"W Reed","year":"2004","unstructured":"Reed W, Bohler PJ, Sandstad B, Nesland JM. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up. Breast J. 2004;10(3):174\u201380. https:\/\/doi.org\/10.1111\/j.1075-122X.2004.21328.x.","journal-title":"Breast J"},{"issue":"11","key":"8582_CR8","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1200\/JCO.2007.12.6425","volume":"26","author":"LK Tan","year":"2008","unstructured":"Tan LK, Giri D, Hummer AJ, Panageas KS, Brogi E, Norton L, et al. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol. 2008;26(11):1803\u20139. https:\/\/doi.org\/10.1200\/JCO.2007.12.6425.","journal-title":"J Clin Oncol"},{"issue":"1","key":"8582_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10549-009-0340-2","volume":"118","author":"D Park","year":"2009","unstructured":"Park D, Karesen R, Naume B, Synnestvedt M, Beraki E, Sauer T. The prognostic impact of occult nodal metastasis in early breast carcinoma. Breast Cancer Res Treat. 2009;118(1):57\u201366. https:\/\/doi.org\/10.1007\/s10549-009-0340-2.","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"8582_CR10","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/cncr.24173","volume":"115","author":"A Loya","year":"2009","unstructured":"Loya A, Guray M, Hennessy BT, Middleton LP, Buchholz TA, Valero V, et al. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Cancer. 2009;115(8):1605\u201312. https:\/\/doi.org\/10.1002\/cncr.24173.","journal-title":"Cancer."},{"issue":"5","key":"8582_CR11","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1200\/JCO.2001.19.5.1468","volume":"19","author":"S Braun","year":"2001","unstructured":"Braun S, Cevatli BS, Assemi C, Janni W, Kentenich CR, Schindlbeck C, et al. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol. 2001;19(5):1468\u201375. https:\/\/doi.org\/10.1200\/JCO.2001.19.5.1468.","journal-title":"J Clin Oncol"},{"issue":"22","key":"8582_CR12","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1158\/1078-0432.CCR-06-0569","volume":"12","author":"P Querzoli","year":"2006","unstructured":"Querzoli P, Pedriali M, Rinaldi R, Lombardi AR, Biganzoli E, Boracchi P, et al. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res. 2006;12(22):6696\u2013701. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0569.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"8582_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1349-7006.2002.tb01308.x","volume":"93","author":"Y Umekita","year":"2002","unstructured":"Umekita Y, Ohi Y, Sagara Y, Yoshida H. Clinical significance of occult micrometastases in axillary lymph nodes in \"node-negative\" breast cancer patients. Jpn J Cancer Res. 2002;93(6):695\u20138. https:\/\/doi.org\/10.1111\/j.1349-7006.2002.tb01308.x.","journal-title":"Jpn J Cancer Res"},{"issue":"5","key":"8582_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1008108","volume":"364","author":"DL Weaver","year":"2011","unstructured":"Weaver DL, Ashikaga T, Krag DN, Skelly JM, Anderson SJ, Harlow SP, et al. Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med. 2011;364(5):412\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1008108.","journal-title":"N Engl J Med"},{"key":"8582_CR15","doi-asserted-by":"crossref","unstructured":"Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group. Lancet. 1990;335:1565\u20138.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/1972494\/.","DOI":"10.1016\/0140-6736(90)91386-O"},{"key":"8582_CR16","doi-asserted-by":"crossref","unstructured":"Valachis A, Nearchou A, Polyzos NP, Lind P, Berqvist J. Occult metastasis in sentinel node: should this affect the clinical decision making? A systematic review and meta-analysis. Cancer Res. 2011;71:(24 Supplement):P3-07-34-P3-07-34.","DOI":"10.1158\/0008-5472.SABCS11-P3-07-34"},{"issue":"4","key":"8582_CR17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1245\/s10434-011-2085-5","volume":"19","author":"T Takeshita","year":"2012","unstructured":"Takeshita T, Tsuda H, Moriya T, Yamasaki T, Asakawa H, Ueda S, et al. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up. Ann Surg Oncol. 2012;19(4):1160\u20136. https:\/\/doi.org\/10.1245\/s10434-011-2085-5.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"8582_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jama.2011.1034","volume":"306","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA. 2011;306(4):385\u201393. https:\/\/doi.org\/10.1001\/jama.2011.1034.","journal-title":"JAMA."},{"key":"8582_CR19","unstructured":"William JD BO, Jame A, Rebecca A, Kimberly HA, Sarah LB, Harold JB, Chau D. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. National Comprehensive Cancer Network; 2021. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf."},{"key":"8582_CR20","doi-asserted-by":"publisher","unstructured":"Fisher ER, Swamidoss S, Lee CH, Rockette H, Redmond C, Fisher B. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer. 1978;42(4):2025\u201331. https:\/\/doi.org\/10.1002\/1097-0142(197810)42:4<2025::AID-CNCR2820420452>3.0.CO;2-J.","DOI":"10.1002\/1097-0142(197810)42:4<2025::AID-CNCR2820420452>3.0.CO;2-J"},{"issue":"7","key":"8582_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/00000478-198210000-00005","volume":"6","author":"PP Rosen","year":"1982","unstructured":"Rosen PP, Saigo PE, Braun DW Jr, Beattie EJ Jr, Kinne DW. Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli. Am J Surg Pathol. 1982;6(7):639\u201341. https:\/\/doi.org\/10.1097\/00000478-198210000-00005.","journal-title":"Am J Surg Pathol"},{"issue":"Pt 2","key":"8582_CR22","first-page":"67","volume":"17","author":"EJ Wilkinson","year":"1982","unstructured":"Wilkinson EJ, Hause LL, Hoffman RG, Kuzma JF, Rothwell DJ, Donegan WL, et al. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol Annu. 1982;17(Pt 2):67\u201391.","journal-title":"Pathol Annu"},{"issue":"3","key":"8582_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/bjc.1992.306","volume":"66","author":"I de Mascarel","year":"1992","unstructured":"de Mascarel I, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer. 1992;66(3):523\u20137. https:\/\/doi.org\/10.1038\/bjc.1992.306.","journal-title":"Br J Cancer"},{"issue":"3","key":"8582_CR24","first-page":"171","volume":"15","author":"CE Elson","year":"1993","unstructured":"Elson CE, Kufe D, Johnston WW. Immunohistochemical detection and significance of axillary lymph node micrometastases in breast carcinoma. A study of 97 cases. Anal Quant Cytol Histol. 1993;15(3):171\u20138.","journal-title":"Anal Quant Cytol Histol"},{"issue":"4","key":"8582_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/bjs.1800800417","volume":"80","author":"PJ Hainsworth","year":"1993","unstructured":"Hainsworth PJ, Tjandra JJ, Stillwell RG, Machet D, Henderson MA, Rennie GC, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg. 1993;80(4):459\u201363. https:\/\/doi.org\/10.1002\/bjs.1800800417.","journal-title":"Br J Surg"},{"issue":"9","key":"8582_CR26","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/0046-8177(93)90108-S","volume":"24","author":"IA Nasser","year":"1993","unstructured":"Nasser IA, Lee AK, Bosari S, Saganich R, Heatley G, Silverman ML. Occult axillary lymph node metastases in \"node-negative\" breast carcinoma. Hum Pathol. 1993;24(9):950\u20137. https:\/\/doi.org\/10.1016\/0046-8177(93)90108-S.","journal-title":"Hum Pathol"},{"issue":"4","key":"8582_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3109\/02841869609109916","volume":"35","author":"A Tsuchiya","year":"1996","unstructured":"Tsuchiya A, Sugano K, Kimijima I, Abe R. Immunohistochemical evaluation of lymph node micrometastases from breast cancer. Acta Oncol. 1996;35(4):425\u20138. https:\/\/doi.org\/10.3109\/02841869609109916.","journal-title":"Acta Oncol"},{"issue":"6","key":"8582_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/BF02303667","volume":"4","author":"SE Clare","year":"1997","unstructured":"Clare SE, Sener SF, Wilkens W, Goldschmidt R, Merkel D, Winchester DJ. Prognostic significance of occult lymph node metastases in node-negative breast cancer. Ann Surg Oncol. 1997;4(6):447\u201351. https:\/\/doi.org\/10.1007\/BF02303667.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"8582_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1524-4741.1997.tb00152.x","volume":"3","author":"B Gerber","year":"1997","unstructured":"Gerber B, Krause A, Reimer T. Immunohistochemically detected lymph-node micrometastases in breast cancer and their correlation with prognostic factors. Breast Journal. 1997;3(3):106\u201311. https:\/\/doi.org\/10.1111\/j.1524-4741.1997.tb00152.x.","journal-title":"Breast Journal"},{"key":"8582_CR30","first-page":"896","volume":"354","author":"RJ Cote","year":"1999","unstructured":"Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Int Breast Cancer Stud Group Lancet. 1999;354:896\u2013900.","journal-title":"Int Breast Cancer Stud Group Lancet"},{"issue":"10","key":"8582_CR31","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1097\/00000478-200210000-00005","volume":"26","author":"MC Cummings","year":"2002","unstructured":"Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG, McGuckin MA. Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis. Am J Surg Pathol. 2002;26(10):1286\u201395. https:\/\/doi.org\/10.1097\/00000478-200210000-00005.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"8582_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/sj.bjc.6600420","volume":"87","author":"I de Mascarel","year":"2002","unstructured":"de Mascarel I, MacGrogan G, Picot V, Mathoulin-Pelissier S. Prognostic significance of immunohistochemically detected breast cancer node metastases in 218 patients. Br J Cancer. 2002;87(1):70\u20134. https:\/\/doi.org\/10.1038\/sj.bjc.6600420.","journal-title":"Br J Cancer"},{"issue":"4","key":"8582_CR33","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/cncr.10741","volume":"95","author":"ER Fisher","year":"2002","unstructured":"Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and bowel (NSABP) protocol B-18. Cancer. 2002;95(4):681\u201395. https:\/\/doi.org\/10.1002\/cncr.10741.","journal-title":"Cancer."},{"issue":"5b","key":"8582_CR34","first-page":"4319","volume":"23","author":"G Gebauer","year":"2003","unstructured":"Gebauer G, Fehm T, Merkle E, Jaeger W, Mitze M. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years. Anticancer Res. 2003;23(5b):4319\u201324.","journal-title":"Anticancer Res"},{"issue":"4","key":"8582_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1075-122X.2006.00267.x","volume":"12","author":"HJ Kahn","year":"2006","unstructured":"Kahn HJ, Hanna WM, Chapman JA, Trudeau ME, Lickley HL, Mobbs BG, et al. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American joint committee on Cancer breast cancer staging system. Breast J. 2006;12(4):294\u2013301. https:\/\/doi.org\/10.1111\/j.1075-122X.2006.00267.x.","journal-title":"Breast J"},{"issue":"4","key":"8582_CR36","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/01.pai.0000210419.45869.79","volume":"14","author":"VF Marinho","year":"2006","unstructured":"Marinho VF, Zagury MS, Caldeira LG, Gobbi H. Relationship between histologic features of primary breast carcinomas and axillary lymph node micrometastases: detection and prognostic significance. Appl Immunohistochem Mol Morphol. 2006;14(4):426\u201331. https:\/\/doi.org\/10.1097\/01.pai.0000210419.45869.79.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"8582_CR37","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.surg.2015.03.049","volume":"158","author":"CW Kimbrough","year":"2015","unstructured":"Kimbrough CW, McMasters KM, Quillo A, Ajkay N. Occult metastases in node-negative breast cancer: a surveillance, epidemiology, and end results-based analysis. Surgery. 2015;158(2):494\u2013500. https:\/\/doi.org\/10.1016\/j.surg.2015.03.049.","journal-title":"Surgery."},{"issue":"9","key":"8582_CR38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"issue":"7414","key":"8582_CR39","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ."},{"issue":"7109","key":"8582_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ."},{"key":"8582_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"EG Armando","year":"2016","unstructured":"Armando EG, Karla B, Linda M, Peter B, Pat WW, Peter B, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons oncology group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg. 2016;264:413\u201320.","journal-title":"Ann Surg"},{"key":"8582_CR42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa0904832","volume":"36","author":"M de Boer","year":"2009","unstructured":"de Boer M, Deurzen CH, Dijck JA, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med. 2009;36:653\u201363.","journal-title":"N Engl J Med"},{"key":"8582_CR43","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/SLA.0b013e31823dc616","volume":"255","author":"JP Manon","year":"2012","unstructured":"Manon JP, Maaike B, Peter B, Jos AD, Carolien HD, Marian BM, et al. Regional recurrence in breast Cancer patients with sentinel node micrometastases and isolated tumor cells. Ann Surg. 2012;255:116\u201321.","journal-title":"Ann Surg"},{"issue":"1","key":"8582_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/bjs.7229","volume":"98","author":"DM Layfield","year":"2011","unstructured":"Layfield DM, Agrawal A, Roche H, Cutress RI. Intraoperative assessment of sentinel lymph nodes in breast cancer. Br J Surg. 2011;98(1):4\u201317. https:\/\/doi.org\/10.1002\/bjs.7229.","journal-title":"Br J Surg"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08582-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08582-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08582-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T22:07:12Z","timestamp":1627682832000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08582-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8582"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08582-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-337175\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]},"assertion":[{"value":"17 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"875"}}